Label

How We Work

Grant

Back

Print

Fraunhofer USA, Inc.


October 2006
to engineer, produce, and assess target antigens for developing a potent and cost-effective vaccine to control and prevent influenza infections
$2,663,930
36
Pneumonia
Global Health
Newark, Delaware
http://www.fraunhofer.org/

Visit Our Blog